ℹ️
🇬🇧
Search
Search for people relevant for "Minimal-Residual-Disease"
Minimal-Residual-Disease
Person
Class
Person
Publication
Programmes
Export current view
MUDr. Markéta Kubričanová Žaliová Ph.D.
Academic staff at Second Faculty of Medicine
81 publications
Publications
publication
IKZF1(plus) Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
2018 |
Second Faculty of Medicine
publication
Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology
2017 |
Second Faculty of Medicine
publication
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study
2016 |
Second Faculty of Medicine
publication
Implications of delayed bone marrow aspirations at the end of treatment induction for risk stratification and outcome in children with acute lymphoblastic leukaemia
2016 |
Second Faculty of Medicine
publication
Aetiology of childhood ALL and AML, molecular genetics and minimal residual disease
2015 |
Second Faculty of Medicine
publication
CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage
2014 |
First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport, Central Library of Charles University
publication
Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia
2014 |
Second Faculty of Medicine
publication
Acute Leukemias with ETV6/ABL1 (TEL/ABL) Fusion: Poor Prognosis and Prenatal Origin
2010 |
First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
publication
Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR/ABL-positive ALL: implications for residual disease monitoring
2009 |
Second Faculty of Medicine
publication
Laboratory testing for the presence of minimal residual disease using DNA-based RQ-PCR for clonal rearrangements of Ig/TCR defined by PCR or massive parallel sequencing (NGS)
Publication without faculty affiliation
Load more publications (71)
Loading network view...